Depressed people often feel “empty” not merely because they are sad, but because depression can alter the body’s energy-regulation systems: immune signalling, stress hormones, sleep, cellular energy production, and the brain circuits that assign value to effort. The result is a felt mismatch between the energy available and the energy a task seems to require.
The core mechanism: effort feels too costly
In depression, the brain’s effort-cost calculation is biased. Tasks that would normally feel neutral or rewarding begin to register as disproportionately demanding, while anticipated reward feels weak or unavailable. This is why “running on empty” is not simply sleepiness: one can sleep for hours and still experience every ordinary action—showering, replying, cooking, speaking—as requiring enormous effort.
Inflammation appears especially relevant to this symptom cluster. Pro-inflammatory signalling can reduce dopamine-related reward and motivation, producing motivational anhedonia: not only reduced pleasure, but reduced willingness to initiate effortful action.
Inflammation and “sickness behaviour”
A major biological pathway involves low-grade inflammation. In depression, particularly in an immuno-metabolic subtype, researchers find elevated markers such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-alpha), alongside fatigue, hypersomnia, increased appetite, and “leaden paralysis.”
These cytokines can signal across the blood–brain barrier and activate microglia, the brain’s immune cells. The resulting state resembles sickness behaviour—the adaptive response during infection in which the body withdraws energy from exploration, social contact, and activity in order to fight illness and repair tissue. In depression, this ancient conservation programme may be activated without an infection that warrants it, producing exhaustion, withdrawal, sleep changes, and loss of interest.
Experimental evidence supports the link: inflammatory challenges such as vaccines or endotoxin can induce fatigue, sleepiness, and anhedonia in healthy people, while interferon-alpha treatment—a deliberately inflammatory therapy—can produce depressive and fatigue-like symptoms.
Stress hormones become miscalibrated
The hypothalamic–pituitary–adrenal (HPA) axis governs the response to stress, including cortisol release. In chronic stress and depression, this system can become dysregulated: cortisol rhythms flatten, feedback control weakens, and glucocorticoid receptors become less responsive.
This matters because cortisol normally helps regulate inflammation and mobilise energy. When its signalling becomes resistant or mistimed, the body may remain in a prolonged defensive state: inflammation persists, sleep and arousal rhythms are disrupted, and the subjective sense of being depleted deepens.
Cellular energy is impaired
“Running on empty” also has a literal metabolic dimension. Mitochondria generate most cellular ATP, and inflammation, oxidative stress, and chronic stress can impair mitochondrial function and reduce the efficiency of energy production.
This does not mean every depressed person has a measurable mitochondrial disease. Rather, it suggests that in some forms of depression, the machinery that converts nutrients into usable cellular energy is under strain. That can contribute to physical fatigue, cognitive slowing, reduced resilience to stress, and the sensation that even minimal exertion depletes one.
Sleep stops restoring
Depression commonly disrupts sleep architecture: sleep may be fragmented, shallow, excessively long, or non-restorative. Poor sleep increases inflammatory signalling, including IL-6 and NF-kappa-B activity, which can in turn worsen fatigue and mood.
This creates a loop: depression disturbs sleep; disturbed sleep amplifies inflammation and reduces daytime functioning; fatigue then makes behavioural activation, exercise, social contact, and routine harder; those losses further entrench depression.
Neurotransmitters and motivation
The older “chemical imbalance” story is too simple, but monoamine systems still matter. Dopamine is central to motivation, reward anticipation, and effort-based decision-making; norepinephrine supports alertness and mobilisation; serotonin affects mood, sleep, and appetite regulation.
Inflammation can interfere with these systems. For example, cytokines can activate the enzyme IDO, shifting tryptophan away from serotonin synthesis toward kynurenine pathways, and can reduce tetrahydrobiopterin (BH4), which is needed for dopamine synthesis.
So the depressed person may not merely “lack willpower”; the neural systems that make action feel worthwhile and feasible may be operating in a low-reward, high-cost mode.
Why it feels like emptiness
Phenomenologically, the experience has several converging sources:
Physical depletion: inflammation, impaired mitochondrial energy metabolism, and non-restorative sleep produce bodily heaviness and low endurance.
Motivational collapse: dopamine and reward-circuit disruption make action feel unrewarding before it is even attempted.
Cognitive fatigue: concentration, working memory, and decision-making require more effort, so ordinary tasks feel mentally expensive.
Stress-system exhaustion: HPA-axis dysregulation keeps the organism in a defensive, poorly regulated state.
Behavioural withdrawal: reduced activity and social contact can further reduce stimulation, circadian stability, and reward, reinforcing the state.
An important qualification
However, the best current account is biopsychosocial: depression-related emptiness arises from interacting biological, psychological, and social processes—not from a single deficient neurotransmitter, and not from a failure of character.
